Wanwan Zhou
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- Extracellular vesicles in disease 3
- RNA modifications and cancer 2
- RNA Research and Splicing 2
-
- Systemic Lupus Erythematosus Research 2
- Co-authors
- Chenggui Miao (7 shared papers)Jun Chang (4 shared papers)Xiao Wang (1 shared paper)Xiao Wang (3 shared papers)Ruixuan Li (2 shared papers)Hao Wu (1 shared paper)Heng He (1 shared paper)Jihong Fang (1 shared paper)
- Journals
- Frontiers in Pharmacology (2 papers)Pharmaceutics (1 paper)Tsinghua Science & Technology (1 paper)Pharmacological Research (1 paper)Applied Catalysis A General (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Wanwan Zhou
11 papers receiving 303 citations
Peers
Comparison fields: 5 of 80
- Cancer Research 78
- Rheumatology 33
- Molecular Biology 160
- Information Systems 41
- Management Information Systems 14
Countries citing papers authored by Wanwan Zhou
This map shows the geographic impact of Wanwan Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wanwan Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wanwan Zhou more than expected).
Fields of papers citing papers by Wanwan Zhou
This network shows the impact of papers produced by Wanwan Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wanwan Zhou. The network helps show where Wanwan Zhou may publish in the future.
Co-authors
The 25 scholars most cited alongside Wanwan Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 60 | |
| 2 | 2021 | 55 | |
| 3 | 2021 | 43 | |
| 4 | 2021 | 37 | |
| 5 | 2022 | 33 | |
| 6 | 2021 | 31 | |
| 7 | 2021 | 20 | |
| 8 | 2023 | 13 | |
| 9 | 2022 | 13 | |
| 10 | 2015 | 4 | |
| 11 | 2025 | 2 |
About Wanwan Zhou
Wanwan Zhou is a scholar working on Molecular Biology, Rheumatology, Information Systems, Artificial Intelligence and Cancer Research, having authored 11 papers that have together received 311 indexed citations. Recurring topics across this work include Extracellular vesicles in disease (3 papers), RNA modifications and cancer (2 papers), Cancer-related molecular mechanisms research (2 papers), RNA Research and Splicing (2 papers), Systemic Lupus Erythematosus Research (2 papers), Caching and Content Delivery (1 paper), Bone and Joint Diseases (1 paper) and Systemic Sclerosis and Related Diseases (1 paper). The work is most often cited by research in Cancer Research (78 citations), Rheumatology (33 citations), Molecular Biology (160 citations), Information Systems (41 citations) and Management Information Systems (14 citations). Wanwan Zhou has collaborated with scholars based in China and United States. Frequent co-authors include Chenggui Miao, Jun Chang, Xiao Wang, Xiao Wang, Ruixuan Li, Hao Wu, Heng He, Xiao Wang, Jihong Fang and Changhui Wang. Their work appears in journals such as Frontiers in Pharmacology, Pharmaceutics, Tsinghua Science & Technology, Pharmacological Research and Applied Catalysis A General.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.